Combined imiquimod and acitretin for non-surgical treatment of basal cell carcinoma

Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery

Volumn 37, Issue 5, 2003, Pages 293-295

  Ingves, Christoffer ^a   Jemec, Gregor B E ^b  

^a Roskilde Amtssygehus ^*  (Denmark)

^b Roskilde Amtssygehus   (Denmark)

Author keywords

Basal cell carcinoma; Imiquimod; Non surgical treatment; Retinoids

Indexed keywords

ETRETIN; IMIQUIMOD;

ADULT; ALOPECIA; ARTICLE; BASAL CELL CARCINOMA; CASE REPORT; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG MIXTURE; FEMALE; HUMAN; HUMAN TISSUE; OUTCOMES RESEARCH; SKIN IRRITATION; TUMOR BIOPSY; XEROSTOMIA;

ACITRETIN; ALGORITHMS; AMINOQUINOLINES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, BASAL CELL; DRUG SYNERGISM; FEMALE; HUMANS; MIDDLE AGED; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 0242267141     PISSN: 02844311     EISSN: None     Source Type: Journal    
DOI: 10.1080/02844310310001724     Document Type: Article

References (22)

1. Berbis P. Acitretine. Ann Dermatol Venereol 2001; 128: 737-745.
2. Bernstein DI, Harrison CJ. Effects of the immunomodulating agent R837 on acute and latent herpes simplex virus type 2 infections. Antimicrob Agents Chemother 1989; 33: 1511-1515.
3. Beutner KR, Geisse JR, Helman D, Fox TL, Ginkel A, Owens ML. Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. J Am Acad Dermatol 1999; 41: 1002-1007.
4. Beutner KR, Tyring SK. Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts. Antimicrob Agents Chemother 1998; 42: 789-794.
5. Chen M, Griffith BP, Lucia HL, Hsiung GD. Efficacy of S26308 against guinea pig cytomegalovirus infection. Antimicrob Agents Chemother 1988; 32: 678-683.
6. Drake LA, Ceilly RI. Guidelines of care for BCC. J Am Acad Dermatol 1992; 26: 117-120.
7. Halpert R, Fruchter RG, Sedlis A, Butt K, Boyce JG, Sillman FH. Human papillomavirus and lower genital neoplasia in renal transplant patients. Obstet Gynecol 1986; 68: 251-258.
8. Hannuksela-Svahn A, Nordal E, Christensen OB. Treatment of multiple basal cell carcinoma in the scalp with imiquimod 5% cream. Acta Derm Venereol 2000; 80: 381-382.
9. Harrison CJ, Jenski L, Miller RL, Bernstein DI. Treatment of genital HSV2 with R837. Antiviral Res 1998; 9: 125.
10. Jablonska S, Majewski S. Immunology of genital papillomavirus infections. In: Gross G, Jablonska S, Pfister H, Stegner HE, eds. Genital papillomavirus infections - 1990. Berlin: Springer-Verlag, 1990: 263-281.
11. Marks R, Gebauer K, Shumack S et al. Imiquimod 5% cream in treatment of superficial basal cell carcinoma: results of a multicenter 6-weeks dose-response trial. J Am Acad Dermatol 2001; 44: 807-813.
12. Marks R, Staples M, Giles GG. Trends in non-melanocytic skin cancer treated in Australia: the second national survey. Int J Cancer 1993; 53: 585-590.
13. Morbidity Statistics. Danish National Board of Health, May 2001.
14. 3M Pharmaceuticals. Data on file (1213-IMIQ), St. Paul: 3M Pharmaceuticals.
15. Ratner D, Skouge JW. Surgical management of local disease. In: Miller SJ, Maloney ME, eds. Cutaneous oncology: pathophysiology, diagnosis and management. Malden (MA): Blackwell Science, 1997: 664-671.
16. Sidky YA, Bryan GT, Weeks CE, Hatcher J, Borden EC. Effects of treatment with the oral interferon inducer, imidazoquinolinamin (R837), on the growth of mouse colon carcinoma FCB. Abstr. II6-12. J Interferon Res 1990; 10 (suppl 1): S123.
17. Slade HB, Owens ML, Tomai MA, Miller RL. Imiquimod 5% cream (Aldara). Exp Opin Invest Drugs 1998; 7: 437-449.
18. Steimann A, Funk JO, Schuler G, Von den Driesch P. Topical imiquimod treatment of a cutaneous melanoma metastasis. J Am Acad Dermatol 2000; 43: 555-556.
19. Suzuki H, Wang B, Shivji GM et al. Imiquimod, a topical immune response modifier, induces migration of Langerhans cells. J Invest Dermatol 2000; 114: 135-141.
20. Testerman TL, Gerster JF, Imbertson LM et al. Cytokin induction by the immunomodulators imiquimod and S-27609. J Leukoc Biol 1995; 58: 365-372.
21. Vincek V. Sunlight induced progression of AIDS. Med Hypotheses 1995; 44: 119-123.
22. Zouboulis CC. Retinoids - which dermatological indications will benefit in the near future? Skin Pharmacol Appl Skin Physiol 2001; 14: 303-315.